Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma
Open Access
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Journal of Infection
- Vol. 80 (4) , 454-461
Abstract
No abstract availableKeywords
Funding Information
- Fundação para a Ciência e a Tecnologia
- Wellcome Trust
- Fred Hollows Foundation
This publication has 36 references indexed in Scilit:
- Causes of vision loss worldwide, 1990–2010: a systematic analysisThe Lancet Global Health, 2013
- Association between Ocular Bacterial Carriage and Follicular Trachoma Following Mass Azithromycin Distribution in The GambiaPLOS Neglected Tropical Diseases, 2013
- Development and Evaluation of a Next-Generation Digital PCR Diagnostic Assay for Ocular Chlamydia trachomatis InfectionsJournal of Clinical Microbiology, 2013
- CT694 and pgp3 as Serological Tools for Monitoring Trachoma ProgramsPLOS Neglected Tropical Diseases, 2012
- A Diagnostics Platform for the Integrated Mapping, Monitoring, and Surveillance of Neglected Tropical Diseases: Rationale and Target Product ProfilesPLOS Neglected Tropical Diseases, 2012
- What Is Causing Active Trachoma? The Role of Nonchlamydial Bacterial Pathogens in a Low Prevalence SettingInvestigative Ophthalmology & Visual Science, 2011
- Constant Ocular Infection with Chlamydia trachomatis Predicts Risk of Scarring in Children in TanzaniaOphthalmology, 2009
- The Genetic Structure of Pacific IslandersPLOS Genetics, 2008
- Strategies for control of trachoma: observational study with quantitative PCRThe Lancet, 2003
- Does the Diagnosis of Trachoma Adequately Identify Ocular Chlamydial Infection in Trachoma‐Endemic Areas?The Journal of Infectious Diseases, 2003